Our results provide the first evidence that OCRL1 does indeed regulate endocytic trafficking in vivo, and support the hypothesis that defects in this process cause the renal tubulopathy of Lowe syndrome and Dent-2 disease. This evidence concerns the gene OCRL and Dent disease.